Andrew Sims's most recent trade in Plus Therapeutics Inc was a trade of 1,533 Restricted Stock Units done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,533 | 28,522 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,533 | 8,489 (0%) | 0% | 0 | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,165 | 27,357 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,165 | 9,654 (0%) | 0% | 0 | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 287 | 27,070 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 287 | 9,941 (0%) | 0% | 0 | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 3,443 | 30,055 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 3,443 | 3,443 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 38,323 | 144,784 (3%) | 1% | 0 | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 38,323 | 694,451 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 29,129 | 665,322 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 29,129 | 173,913 (4%) | 0% | 0 | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 349,542 | 732,774 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 349,541 | 349,541 | - | - | Stock Option (Right to Buy) | |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Sale or transfer of securities back to the company at price $ 2.25 per share. | 12 Feb 2026 | 826,909 | 0 (0%) | 5% | 2.2 | 1,860,545 | Common Stock |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Sale or transfer of securities back to the company at price $ 2.25 per share. | 12 Feb 2026 | 793,937 | 0 (0%) | 5% | 2.2 | 1,786,358 | Common Stock |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Sale or transfer of securities back to the company at price $ 2.25 per share. | 12 Feb 2026 | 107,490 | 0 (0%) | 0% | 2.3 | 241,853 | Common Stock |
| Plus Therapeutics Inc | Sims Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 38,323 | 106,461 (2%) | 1% | 0 | Common Stock | |
| Plus Therapeutics Inc | Sims Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 38,323 | 383,232 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.51 per share. | 04 Nov 2025 | 20,000 | 68,138 (1%) | 0% | 0.5 | 10,200 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 38,323 | 421,555 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 38,323 | 48,138 (1%) | 1% | 0 | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 1,379,636 | 1,379,636 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 1,379,636 | 1,379,636 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 459,878 | 459,878 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 459,878 | 459,878 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 60,020 | 60,020 | - | - | Stock Option (Right to Buy) | |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 60,000 | 826,909 (5%) | 0% | - | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 46,074 | 46,074 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 10 Sep 2024 | 4,098 | 9,815 (0%) | 0% | 1.3 | 5,204 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 9,804 | 9,804 | - | - | Warrants (Right to buy) | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 08 May 2024 | 4,902 | 5,717 (0%) | 0% | 2.0 | 10,000 | Common Stock |
| Plus Therapeutics Inc | Sims Andrew | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 18,933 | 18,933 | - | - | Stock Option (Right to Buy) | |
| Sotherly Hotels Inc | Sims M. Andrew | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 23,715 | 685,267 (4%) | 0% | - | Common Stock | |
| Sotherly Hotels Inc | M. Andrew Sims | Director, Chairman | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 18 Sep 2023 | 1,133 | 326,570 (2%) | 0% | 1.8 | 2,040 | Common Stock |
| Sotherly Hotels Inc | Sims Andrew M. | Director, Chairman | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 18 Sep 2023 | 200 | 327,703 (2%) | 0% | 1.8 | 360 | Common Stock |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | 18 Aug 2023 | 252,903 | 327,903 (2%) | 1% | - | Common Stock | ||
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | 18 Aug 2023 | 252,903 | 0 | - | - | Operating Partnership Units | ||
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | 28 Apr 2023 | 75,000 | 252,903 | - | - | Operating Partnership Units | ||
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | 28 Apr 2023 | 75,000 | 75,000 (0%) | 0% | - | Common Stock | ||
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Sale of securities on an exchange or to another person at price $ 1.98 per share. | 29 Mar 2023 | 20,000 | 0 (0%) | 0% | 2.0 | 39,660 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 104,404 | 104,404 | - | - | Stock Option (Right to Buy) | |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 75,000 | 504,302 (3%) | 0% | - | Common Stock | |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Sale of securities on an exchange or to another person at price $ 2.14 per share. | 19 Sep 2022 | 30,000 | 20,000 (0%) | 0% | 2.1 | 64,308 | Common Stock |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 72,816 | 429,302 (3%) | 0% | - | Common Stock | |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | 19 May 2022 | 50,000 | 50,000 (0%) | 0% | - | Common Stock | ||
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | 19 May 2022 | 50,000 | 327,903 | - | - | Operating Partnership Units | ||
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 26 Apr 2022 | 3,000 | 12,230 (0%) | 0% | 0.7 | 2,016 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 01 Mar 2022 | 2,000 | 9,230 (0%) | 0% | 1.1 | 2,200 | Common Stock |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 11,681 | 356,486 (2%) | 0% | - | Common Stock | |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 02 Nov 2021 | 1,000 | 7,230 (0%) | 0% | 1.9 | 1,864 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 26 Oct 2021 | 2,000 | 6,230 (0%) | 0% | 1.7 | 3,339 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 27 Jul 2021 | 2,244 | 4,230 (0%) | 0% | 1.9 | 4,286 | Common Stock |
| Plus Therapeutics Inc | Andrew Sims | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 27 Jul 2021 | 1,986 | 1,986 (0%) | 0% | 2.0 | 4,071 | Common Stock |